ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients

March 14, 1980

Funding opportunities listed.

February 6, 2004

Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget

March 15, 1974

Task Force: No Routine Mammograms Until 50

November 20, 2009

Centers: Bookman Leaves Fox Chase for Arizona

September 11, 2009

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007